| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 33.488 | 293.568 | 531.770 | 638.390 |
| Total Income - EUR | - | - | - | - | - | - | 33.488 | 293.569 | 531.772 | 638.392 |
| Total Expenses - EUR | - | - | - | - | - | - | 290 | 68.892 | 142.300 | 216.168 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 33.197 | 224.677 | 389.472 | 422.224 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 32.192 | 221.741 | 366.823 | 354.668 |
| Employees | - | - | - | - | - | - | 0 | 15 | 20 | 20 |
Check the financial reports for the company - Clinica Doinamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 377.478 | 362.163 | 328.955 |
| Current Assets | - | - | - | - | - | - | 33.237 | 196.593 | 552.228 | 353.008 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 33.153 | 185.252 | 546.544 | 348.269 |
| Cash | - | - | - | - | - | - | 85 | 11.341 | 5.684 | 4.739 |
| Shareholders Funds | - | - | - | - | - | - | 32.233 | 254.074 | 620.127 | 368.229 |
| Social Capital | - | - | - | - | - | - | 40 | 20.278 | 20.216 | 20.103 |
| Debts | - | - | - | - | - | - | 1.005 | 319.997 | 294.264 | 313.734 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Clinica Doinamed S.r.l.